ClinVar Miner

Submissions for variant NM_005360.5(MAF):c.295_312delinsTGCA (p.Gln99fs)

dbSNP: rs1555530022
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000652087 SCV000773955 pathogenic Cataract 21 multiple types; Ayme-Gripp syndrome 2019-07-26 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg294 amino acid residue in MAF. Other variant(s) that disrupt this residue have been observed in individuals with MAF-related conditions (PMID:24968223, 26694549, Invitae), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. This variant has been observed to segregate with clinical features of MAF-related cataracts in a family (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the MAF gene (p.Leu101Argfs*63). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 305 amino acids of the MAF protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.